Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making

Bisphosphonates are first-line therapy for osteoporosis, with alendronate, risedronate, and zoledronate as the main treatments used globally. After one year of therapy, bisphosphonates are retained in bone for extended periods with extended anti-fracture effects after discontinuation. Due to this co...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayes, Kaleen N., Winter, Elizabeth M., Cadarette, Suzanne M., Burden, Andrea M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963175/
https://www.ncbi.nlm.nih.gov/pubmed/33803095
http://dx.doi.org/10.3390/jcm10051140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963175/
https://www.ncbi.nlm.nih.gov/pubmed/33803095
http://dx.doi.org/10.3390/jcm10051140

Ejemplares similares